HealthEquity’s Q2 2026: An HSA-Driven Quarter That Raises the Bar and the Guidance

HealthEquity, Inc. (HQY) delivered a second-quarter update that reads as a careful victory lap for an asset-light, growth-by-education business: EPS of $0.78 per diluted share on GAAP earnings, and non-GAAP earnings per diluted share of $1.24. Revenue came in at $350.7 million, an 8% year-over-year ascent, while Adjusted EBITDA climbed 11% to $167.0 million and carved out a margin of 48%—two percentage points better than a year ago. The company also reported record health-savings accounts (HSAs) and assets, delivering a familiar drumbeat of growth that investors have come to expect in this space. In plain terms: the HSA custodian is not merely keeping score; it’s expanding the playground.

Key financials at a glance

Ticker: HQY (HealthEquity, Inc.)
EPS (diluted GAAP): $0.78
Non-GAAP EPS (diluted): $1.24
Revenue: $350.7 million, up 8% year over year
Net income: $65.6 million
Adjusted EBITDA: $167.0 million; Adjusted EBITDA margin 48% (vs 46% prior year)
HSA accounts: 10.7 million (record)
HSA assets: $37.9 billion (record)
Shareholder returns: $108.1 million returned via stock repurchases
Guidance: Management raised fiscal 2027 expectations

Where the money came from

The quarterly cadence underscored a familiar mix for HealthEquity: service revenue contributed $124.4 million, custodial revenue was $175.9 million, and interchange revenue totaled $50.4 million. The structure reinforces a diversified revenue profile tied to member activity and account volumes, with growth aided by expanding HSA adoption and deeper engagement across the company’s technology-enabled platform.

What the company says—and what it might mean

In a line that could double as a forecast, CEO Scott Cutler framed the quarter as “record-setting,” pointing to a combination of durable earnings power and operating efficiency. The message is clear: growth isn’t a fluke of a single product cycle; it’s a function of scale—more accounts, more assets, and a platform that translates member activity into durable margin lift.

The standout stat here is the Adjusted EBITDA margin at 48%, a two-point improvement year over year. That is the kind of margin expansion that attracts both equity investors and corporate strategists—especially in a sector where the value proposition centers on consumer-directed benefits and the efficiency of digital interfaces to manage cash flows and benefits delivery.

Earnings context: EPS, consensus, and the revenue outlook

The reported EPS of $0.78 per diluted share sits alongside a non-GAAP EPS of $1.24 per diluted share, underscoring the separation between GAAP results and the company’s preferred metric set. While the press release highlights a strong quarter, it does not explicitly frame an “earnings surprise” relative to external EPS consensus in the public narrative. Still, the raise in fiscal 2027 guidance suggests management’s view that the revenue forecast and margin trajectory will sustain growth beyond the current quarter.

For investors, the headline numbers are more than just a ledger entry; they offer a signal about the fundamental trajectory of HQY’s core business—HSAs and related services—rather than a one-off efficiency push. The combination of higher revenue, stable mix, and a robust asset base may influence sector peers by emphasizing scale effects in HSA ecosystems, and by validating a model where more accounts yield more assets and more opportunity for margin leverage.

Implications for Health Savings, and peers

HealthEquity’s results reinforce a narrative in which HSAs remain a growth anchor in consumer-directed benefits. The 14% rise in Total HSA assets to $37.9 billion aligns with a broader trend of increasing consumer health spend and tax-advantaged savings activity. For sector peers, the emphasis on user growth, asset scale, and a high-visibility buyback program could become a template for capital allocation—combine revenue diversity with capital returns while dialing up efficiency offsets.

Bottom line

HealthEquity’s Q2 2026 results deliver a tidy package: higher revenue, better margins, and a robust asset base—all supported by a compelling member and account trajectory. The raised fiscal 2027 guidance hints at confidence in continued demand and efficiency gains, even as the company maintains a clear preference for returning capital to shareholders. In the world of HQY, the newsletter-worthy takeaway is not just the numbers, but the sustained rhythm of growth that keeps the company’s HSA engine humming.